ECZACIBAŞI YATIRIM HOLDİNG ORTAKLIĞI A.Ş. İlişkili Taraf İşlemleri 6 Mart 2023

The conclusion section of the "Report on Common and Continuous Related Party Transactions" ("Report"), prepared by the Board of Directors of our Company in accordance with Article 10 of the Communiqué on Corporate Governance No. II-17.1 of the Capital Markets Board is presented to the information of our shareholders below.

The Conclusion Section of the Report:

In accordance with Article 10 of the Communiqué on Corporate Governance No. II-17.1 of the Capital Markets Board, the volume of service procurement of our Company within the year 2022 amounting to TRY 10,603,622 from Eczacıbaşı Holding A.Ş. and TRY 42,957 from Eczacıbaşı Bilişim Sanayi ve Ticaret A.Ş.; and TRY 16,865 for the leasing transaction carried out by Eczacıbaşı İlaç Sınai ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş. in the 2022 accounting period have reached more than 10% of the cost of sales included in the 2022 financial statements. It was concluded that the said transactions carried out in 2022 were reasonable according to the market conditions. In 2023, it is foreseen that the transactions with Eczacıbaşı Holding A.Ş., Eczacıbaşı Bilişim Sanayi ve Ticaret A.Ş. and Eczacıbaşı İlaç Sınai ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş. will exceed 10% and by evaluating the conditions of the transactions to be continued under similar conditions, the price determination method and the reasons for choosing this method, it has been concluded that the transactions are in line with previous years and compatible with market conditions.

This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.